The Allstate Corporation (ALL) is one of the largest property and casualty insurers in the United States, selling personal auto, homeowners, life insurance, and retirement products across the U.S. and Canada. After a strong multi-year run, the shares have consolidated below their 52-week high, leaving investors asking whether the stock can reclaim higher ground. This article examines whether a move toward a $290 price target is realistic, based on recent analyst price targets and current market conditions.
Recent coverage of Allstate is unusually divided. Across roughly 15 firms tracked in recent weeks, targets span from about $191 to $340. Because the mean of all valid targets (approximately $269) sits only a few percentage points above the current price, it does not represent a meaningful upside scenario. The central $290 target is therefore calculated as the average of the recent analyst targets that sit above the current share price, a group of roughly nine targets that rounds to $290.
The bullish camp is led by Bank of America Securities, which raised its target to $340 in October, while Mizuho ($295), Jefferies ($292), and JPMorgan ($292) also see meaningful upside on the strength of underwriting profitability and pricing power. HSBC upgraded the stock to Buy with a $266 target, and Evercore ISI lifted its target to $262. The cautious camp is equally vocal: Citi cut to $215 with a Sell rating, Barclays lowered to $221, and Keefe, Bruyette & Woods trimmed to $232. Morgan Stanley ($240), Goldman Sachs ($250), and Wells Fargo ($236, upgraded to Equal-Weight) sit in the middle. The spread reflects genuine disagreement over how Allstate will navigate auto loss costs and catastrophe exposure.
With shares near $259.87, a move to $290 implies a rise of about 11.6%, a substantial but not extreme advance that would carry the stock above its 52-week high of roughly $277. Achieving it would likely require evidence that personal auto margins are stabilizing and that catastrophe losses return to more normal levels. Trailing twelve-month EPS (earnings per share) of about $50 and a P/E (price-to-earnings) ratio near 5 reflect a market that is pricing in earnings normalization rather than continued record profitability. Any path to $290 depends less on multiple expansion than on the durability of recent underwriting results.
The 52-week high near $277 is the most important near-term resistance, and a sustained move through it would open the door toward the $290 area. On the downside, the $250 round-number level and the $236-to-$240 zone, where several analyst targets cluster, represent meaningful support. The stock's consolidation below its prior high suggests that buyers have so far been unwilling to push through, making the $277 area a key threshold to watch.
Analyst price targets generally reflect a roughly 12-month research horizon, though individual firms differ in their assumptions. The most important near-term catalyst is the third-quarter earnings report, expected in early November, which will reveal the impact of catastrophe losses and any commentary on auto margins and pricing. Investors should also monitor analyst target revisions, catastrophe-loss announcements, inflation data affecting claim costs, and Federal Reserve rate decisions, which influence the fixed-income returns that insurers earn on their investment portfolios.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals from evolving market conditions, technical behavior, and AI-driven analysis. This approach helps traders discover opportunities, track existing positions, and identify changing trends more efficiently than manual screening alone. For investors following Allstate, such signals can add a systematic layer to fundamental research. Explore the platform to see how AI-driven signals can support your market monitoring.
The $290 target is the average of the recent analyst price targets above the current price, reflecting a bullish-leaning but contested view. It requires roughly 11.6% upside, a move that would take Allstate to new highs and depends on stabilizing auto margins and normalizing catastrophe losses. Strong profitability, cheap valuation, and pricing power support the case, while catastrophe exposure, loss-cost inflation, and AI-driven shopping disruption are the principal obstacles. With the overall analyst mean near $269 and a range spanning $191 to $340, Wall Street remains genuinely split. Whether Allstate can reach $290 will hinge on the upcoming earnings report and whether underwriting results justify the optimism of the stock's most bullish analysts.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, ALL has been closely correlated with HIG. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if ALL jumps, then HIG could also see price increases.